Form 4: Clover Health Director Vivek Garipalli Executes Stock Transactions Following RSU Vesting

Director Vivek Garipalli of Clover Health Investments, Corp. executed transactions involving Class A and Class B common stock following the vesting of restricted stock units.

Summary

• Vivek Garipalli, a director at Clover Health Investments, Corp., reported transactions on January 7, 2025, related to the vesting of restricted stock units (RSUs).
• A total of 1,670,965 shares of Class B Common Stock were converted to Class A Common Stock and withheld to cover tax obligations.
• Garipalli also acquired 1,670,965 shares of Class B Common Stock upon vesting of the RSUs.
• Following these transactions, Garipalli directly owns 1,409,267 shares of Class A Common Stock and indirectly owns significant amounts through various LLCs.
• The RSUs vest in equal installments over five years from January 7, 2021.

Sentiment

Score: 7

Explanation: The document reflects routine insider transactions related to vesting of stock options, which is a normal part of executive compensation. There is no indication of any negative or positive sentiment.

Positives

• The vesting of RSUs indicates continued alignment of interests between the director and the company.
• The conversion of Class B shares to Class A shares is a standard process for tax obligations.

Risks

• The document does not indicate any specific risks.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders reporting transactions in their company's stock. It is a routine disclosure and does not indicate any unusual activity.

Comparison to Industry Standards

• Form 4 filings are a standard practice for publicly traded companies in the US, and this filing is consistent with those standards.
• The vesting of RSUs and subsequent tax withholding is a common practice in executive compensation.
• The conversion of Class B shares to Class A shares is a standard mechanism for companies with dual-class stock structures.

Stakeholder Impact

• The transactions do not have a significant impact on stakeholders as they are routine insider transactions.

Key Dates

Keywords

Form 4, Clover Health, CLOV, Vivek Garipalli, Restricted Stock Units, RSU, Class A Common Stock, Class B Common Stock, Beneficial Ownership, Director